Control of Paramyxovirus RNA Synthesis

副粘病毒 RNA 合成的控制

基本信息

项目摘要

DESCRIPTION (provided by applicant): Our recent work has led to the overall hypothesis that following infection, paramyxoviruses delay abundant RNA synthesis to provide time for virus-mediated suppression of host anti-virus responses. This hypothesis emerged from our results with variants of the prototype paramyxovirus Simian Virus 5 (SV5) that have either accelerated or delayed kinetics of RNA synthesis. A remarkable result from this work was our finding that mutations in the P/V gene that accelerate viral RNA synthesis also convert SV5 from a noncytopathic virus into a virus that activates type I interferon (IFN) and kills cells by apoptosis. Thus, the overall goal of our work is to understand mechanisms that can accelerate or delay paramyxovirus RNA synthesis and how changes in the timing of viral gene expression affect key virus:host cell interactions. We have isolated a naturally-occurring SV5 variant (WF-CPIV) that shows a remarkable delay in viral gene expression compared to WT SV5. In Aim 1, we will determine the basis for the delay in WF-CPIV gene expression. Real-time PCR assays will be used to test the hypotheses that delayed WF-CPIV gene expression is due to a defect in either primary or secondary transcription. Recombinant SV5 viruses containing exchanges of polymerase-associate genes will identify WF-CPIV component(s) responsible for delayed gene expression. Aim 2 addresses our finding that an rSV5 with substitutions in the P/V gene expresses viral mRNA and proteins earlier and to higher levels than WT rSV5. Novel rSV5 viruses will be generated that express WT or mutant P and V proteins from separate transcription units. Biochemical and minigenome replication assays will be used to test the hypotheses that P/V substitutions either decrease the ability of V to inhibit SV5 genome replication or confer higher RNA synthesis activity on the P protein. In Aim 3, we will test the hypothesis that the cytopathic rSV5 variant containing P/V substitutions induces interferon (IFN) synthesis and apoptosis due to premature expression of viral gene products. Cell lines with inducible expression of WT and mutant P and V proteins, and new rSV5 P/V mutants will be used to test a two-step model for the role of accelerated and delayed SV5 RNA synthesis in the induction of IFN and apoptosis. We hypothesize that paramyxoviruses have evolved to optimize the timing of the onset of viral gene expression to avoid host antiviral responses, and changes that accelerate or significantly delay RNA synthesis can activate IFN and/or apoptotic pathways. Our work will increase our understanding of important virus-host cell interactions, as well as provide new approaches to improve the safety and potency of vaccine vectors.
描述(由申请人提供):我们最近的工作导致了一个总体假设,即在感染后,副粘病毒延迟大量RNA合成,为病毒介导的宿主抗病毒反应抑制提供时间。这一假设来自于我们对原型副粘病毒猿猴病毒5 (SV5)的变异体的研究结果,这些变异体加速或延迟了RNA合成动力学。这项工作的一个显著结果是我们发现加速病毒RNA合成的P/V基因突变也将SV5从一种非细胞病变病毒转化为一种激活I型干扰素(IFN)并通过凋亡杀死细胞的病毒。因此,我们工作的总体目标是了解可以加速或延迟副粘病毒RNA合成的机制,以及病毒基因表达时间的变化如何影响关键病毒:宿主细胞相互作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Griffith D. Parks其他文献

Complement evasion by vesicular stomatitis virus involves recruitment of host complement regulatory proteins
  • DOI:
    10.1016/j.molimm.2010.05.129
  • 发表时间:
    2010-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    John B. Johnson;Douglas S. Lyles;Griffith D. Parks
  • 通讯作者:
    Griffith D. Parks

Griffith D. Parks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Griffith D. Parks', 18)}}的其他基金

Complement Resistance Acquired During Acute to Persistent Rubulavirus Infection
急性至持续性风疹病毒感染期间获得的补体耐药性
  • 批准号:
    10645486
  • 财政年份:
    2023
  • 资助金额:
    $ 24.52万
  • 项目类别:
Assembly of Live Nipah Virus with Complement Factors
活尼帕病毒与补体因子的组装
  • 批准号:
    8896985
  • 财政年份:
    2012
  • 资助金额:
    $ 24.52万
  • 项目类别:
Assembly of Live Nipah Virus with Complement Factors
活尼帕病毒与补体因子的组装
  • 批准号:
    8470128
  • 财政年份:
    2012
  • 资助金额:
    $ 24.52万
  • 项目类别:
Assembly of Live Nipah Virus with Complement Factors
活尼帕病毒与补体因子的组装
  • 批准号:
    8358727
  • 财政年份:
    2012
  • 资助金额:
    $ 24.52万
  • 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
  • 批准号:
    8286153
  • 财政年份:
    2011
  • 资助金额:
    $ 24.52万
  • 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
  • 批准号:
    8897063
  • 财政年份:
    2011
  • 资助金额:
    $ 24.52万
  • 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
  • 批准号:
    8469683
  • 财政年份:
    2011
  • 资助金额:
    $ 24.52万
  • 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
  • 批准号:
    8848749
  • 财政年份:
    2011
  • 资助金额:
    $ 24.52万
  • 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
  • 批准号:
    8660023
  • 财政年份:
    2011
  • 资助金额:
    $ 24.52万
  • 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
  • 批准号:
    8039506
  • 财政年份:
    2011
  • 资助金额:
    $ 24.52万
  • 项目类别:

相似海外基金

RNA BIOSYNTHESIS IN ESCHERICHIA COLI
大肠杆菌中的 RNA 生物合成
  • 批准号:
    6125388
  • 财政年份:
    1993
  • 资助金额:
    $ 24.52万
  • 项目类别:
RNA BIOSYNTHESIS IN ESCHERICHIA COLI
大肠杆菌中的 RNA 生物合成
  • 批准号:
    2468901
  • 财政年份:
    1993
  • 资助金额:
    $ 24.52万
  • 项目类别:
RNA BIOSYNTHESIS IN ESCHERICHIA COLI
大肠杆菌中的 RNA 生物合成
  • 批准号:
    2186807
  • 财政年份:
    1993
  • 资助金额:
    $ 24.52万
  • 项目类别:
RNA BIOSYNTHESIS IN ESCHERICHIA COLI
大肠杆菌中的 RNA 生物合成
  • 批准号:
    2186806
  • 财政年份:
    1993
  • 资助金额:
    $ 24.52万
  • 项目类别:
RNA BIOSYNTHESIS IN ESCHERICHIA COLI
大肠杆菌中的 RNA 生物合成
  • 批准号:
    2186805
  • 财政年份:
    1993
  • 资助金额:
    $ 24.52万
  • 项目类别:
RNA BIOSYNTHESIS IN ESCHERICHIA COLI
大肠杆菌中的 RNA 生物合成
  • 批准号:
    6329742
  • 财政年份:
    1993
  • 资助金额:
    $ 24.52万
  • 项目类别:
RNA BIOSYNTHESIS IN ESCHERICHIA COLI
大肠杆菌中的 RNA 生物合成
  • 批准号:
    3308590
  • 财政年份:
    1993
  • 资助金额:
    $ 24.52万
  • 项目类别:
RNA BIOSYNTHESIS IN ESCHERICHIA COLI
大肠杆菌中的 RNA 生物合成
  • 批准号:
    2838605
  • 财政年份:
    1993
  • 资助金额:
    $ 24.52万
  • 项目类别:
The Control of RNA Biosynthesis in Bacteria
细菌中 RNA 生物合成的控制
  • 批准号:
    66B4535
  • 财政年份:
    1966
  • 资助金额:
    $ 24.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了